CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Ibrutinib

伊布替尼 杂质对照品Ibrutinib Impurities

95 个杂质条目95 impurity entries

本页汇总 伊布替尼 的 95 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 95 impurity reference standards of Ibrutinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 伊布替尼(Ibrutinib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of a stability-indicating ultra-high-performance liquid chromatography method for the estimation of ibrutinib and trace-level quantification of related substances using quality-by-design approach
    Biomedical chromatography : BMC · 2024 · Prasad SK, Kalpana D  ·  PMID 38081478  ·  DOI
  2. 杂质研究Impurity studiesA Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Ibrutinib Using QbD Approach by RP-HPLC, NMR Spectroscopy and ESI-MS
    Journal of chromatographic science · 2021 · Gopireddy RR et al.  ·  PMID 33420506  ·  DOI
  3. 杂质研究Impurity studiesStructural Elucidation of Novel Degradation Impurities of Ibrutinib in Ibrutinib Tablets Using Preparative Chromatography, LCMS, HRMS and 2D NMR Techniques
    Journal of chromatographic science · 2025 · Yerla RR et al.  ·  PMID 38336469  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of [(13) C(6) ]-ibrutinib
    Journal of labelled compounds & radiopharmaceuticals · 2021 · Kriegelstein M et al.  ·  PMID 34478181  ·  DOI
  • 合成方法SynthesisEfficient synthesis of Ibrutinib chiral intermediate in high space-time yield by recombinant E. coli co-expressing alcohol dehydrogenase and glucose dehydrogenase
    RSC advances · 2019 · Chen Y et al.  ·  PMID 35516114  ·  DOI

伊布替尼 —— 原料药与杂质对照品Ibrutinib — drug substance & impurities

共 96 个条目(含原料药本体)96 items incl. the drug substance
Ibrutinib structure
原料药 APIAPI
伊布替尼Ibrutinib
Ibrutinib
CAS No.936563-96-1
Chemical FormulaC25H24N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 1 structure
1
伊布替尼杂质1Ibrutinib Impurity 1
Ibrutinib Impurity 1
CAS No.936563-97-2
Chemical FormulaC25H24N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 2 structure
2
伊布替尼杂质2Ibrutinib Impurity 2
Ibrutinib Impurity 2
CAS No.2031255-27-1
Chemical FormulaC28H26N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 5 structure
5
伊布替尼杂质5Ibrutinib Impurity 5
Ibrutinib Impurity 5
CAS No.1839099-22-7
Chemical FormulaC25H26N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 6 structure
6
伊布替尼杂质6Ibrutinib Impurity 6
Ibrutinib Impurity 6
CAS No.1288338-96-4
Chemical FormulaC25H25ClN6O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 7 structure
7
伊布替尼杂质7Ibrutinib Impurity 7
Ibrutinib Impurity 7
CAS No.1288338-95-3
Chemical FormulaC24H24N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 8 structure
8
伊布替尼杂质8Ibrutinib Impurity 8
Ibrutinib Impurity 8
CAS No.330786-24-8
Chemical FormulaC17H13N5O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 9 structure
9
伊布替尼杂质9Ibrutinib Impurity 9
Ibrutinib Impurity 9
CAS No.2031255-23-7
Chemical FormulaC50H48N12O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 10(PCI-45227) structure
10
伊布替尼杂质10(PCI-45227)Ibrutinib Impurity 10(PCI-45227)
Ibrutinib Impurity 10(PCI-45227)
CAS No.1654820-87-7
Chemical FormulaC25H26N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 11 structure
11
伊布替尼杂质11Ibrutinib Impurity 11
Ibrutinib Impurity 11
CAS No.936563-92-7
Chemical FormulaC25H24N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 13 structure
13
伊布替尼杂质13Ibrutinib Impurity 13
Ibrutinib Impurity 13
CAS No.1642571-08-1
Chemical FormulaC27H30N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 16 structure
16
伊布替尼杂质16Ibrutinib Impurity 16
Ibrutinib Impurity 16
CAS No.1642630-12-3
Chemical FormulaC22H22N6O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 17 structure
17
伊布替尼杂质17Ibrutinib Impurity 17
Ibrutinib Impurity 17
CAS No.330792-70-6
Chemical FormulaC16H12N4O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 18 structure
18
伊布替尼杂质18Ibrutinib Impurity 18
Ibrutinib Impurity 18
CAS No.1881246-01-0
Chemical FormulaC16H12N4O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 20 structure
20
伊布替尼杂质20Ibrutinib Impurity 20
Ibrutinib Impurity 20
CAS No.86953-81-3
Chemical FormulaC10H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 22 structure
22
伊布替尼杂质22Ibrutinib Impurity 22
Ibrutinib Impurity 22
CAS No.24211-55-0
Chemical FormulaC5H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 24 structure
24
伊布替尼杂质24Ibrutinib Impurity 24
Ibrutinib Impurity 24
CAS No.2244619-11-0
Chemical FormulaC28H28N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 25 structure
25
伊布替尼杂质25Ibrutinib Impurity 25
Ibrutinib Impurity 25
CAS No.2052279-48-6
Chemical FormulaC28H28N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 26 structure
26
伊布替尼杂质26Ibrutinib Impurity 26
Ibrutinib Impurity 26
CAS No.2417548-76-4
Chemical FormulaC50H48N12O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 27 structure
27
伊布替尼杂质27Ibrutinib Impurity 27
Ibrutinib Impurity 27
CAS No.2031255-26-0
Chemical FormulaC26H28N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 28 structure
28
伊布替尼杂质28Ibrutinib Impurity 28
Ibrutinib Impurity 28
CAS No.2213398-75-3
Chemical FormulaC18H15N5O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 29 structure
29
伊布替尼杂质29Ibrutinib Impurity 29
Ibrutinib Impurity 29
CAS No.1838132-94-7
Chemical FormulaC25H26N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 31 structure
31
伊布替尼杂质31Ibrutinib Impurity 31
Ibrutinib Impurity 31
CAS No.2417548-74-2
Chemical FormulaC25H24N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 32 structure
32
伊布替尼杂质32Ibrutinib Impurity 32
Ibrutinib Impurity 32
CAS No.143900-44-1
Chemical FormulaC10H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 33 structure
33
伊布替尼杂质33Ibrutinib Impurity 33
Ibrutinib Impurity 33
CAS No.1022150-12-4
Chemical FormulaC22H22N6O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 33 Dihydrochloride structure
33
伊布替尼杂质33 双盐酸盐Ibrutinib Impurity 33 Dihydrochloride
Ibrutinib Impurity 33 Dihydrochloride
CAS No.1701403-10-2
Chemical FormulaC22H22N6O·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 34 structure
34
伊布替尼杂质34Ibrutinib Impurity 34
Ibrutinib Impurity 34
CAS No.1226872-27-0
Chemical FormulaC25H26N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 35 structure
35
伊布替尼杂质35Ibrutinib Impurity 35
Ibrutinib Impurity 35
CAS No.151266-23-8
Chemical FormulaC5H4IN5
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 36 structure
36
伊布替尼杂质36Ibrutinib Impurity 36
Ibrutinib Impurity 36
CAS No.51067-38-0
Chemical FormulaC12H11BO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 37 structure
37
伊布替尼杂质37Ibrutinib Impurity 37
Ibrutinib Impurity 37
CAS No.330793-49-2
Chemical FormulaC10H13IN6
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 38 structure
38
伊布替尼杂质38Ibrutinib Impurity 38
Ibrutinib Impurity 38
CAS No.1022150-11-3
Chemical FormulaC27H30N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 39 structure
39
伊布替尼杂质39Ibrutinib Impurity 39
Ibrutinib Impurity 39
CAS No.1917333-91-5
Chemical FormulaC28H26N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 40 structure
40
伊布替尼杂质40Ibrutinib Impurity 40
Ibrutinib Impurity 40
CAS No.1987905-93-0
Chemical FormulaC47H46N12O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 42 structure
42
伊布替尼杂质42Ibrutinib Impurity 42
Ibrutinib Impurity 42
CAS No.143900-43-0
Chemical FormulaC10H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 44 structure
44
伊布替尼杂质44Ibrutinib Impurity 44
Ibrutinib Impurity 44
CAS No.1412418-47-3
Chemical FormulaC22H22N6O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 49 structure
49
伊布替尼杂质49Ibrutinib Impurity 49
Ibrutinib Impurity 49
CAS No.1839150-56-9
Chemical FormulaC26H29N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 50 structure
50
伊布替尼杂质50Ibrutinib Impurity 50
Ibrutinib Impurity 50
CAS No.936563-87-0
Chemical FormulaC25H24N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 54 structure
54
伊布替尼杂质54Ibrutinib Impurity 54
Ibrutinib Impurity 54
CAS No.109-00-2
Chemical FormulaC5H5NO
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 56 structure
56
伊布替尼杂质56Ibrutinib Impurity 56
Ibrutinib Impurity 56
CAS No.2102325-71-1
Chemical FormulaC11H21NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 57 structure
57
伊布替尼杂质57Ibrutinib Impurity 57
Ibrutinib Impurity 57
CAS No.85275-45-2
Chemical FormulaC10H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 58 structure
58
伊布替尼杂质58Ibrutinib Impurity 58
Ibrutinib Impurity 58
CAS No.98977-36-7
Chemical FormulaC10H17NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 65 structure
65
伊布替尼杂质65Ibrutinib Impurity 65
Ibrutinib Impurity 65
CAS No.330793-52-7
Chemical FormulaC21H20N6O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 66 structure
66
伊布替尼杂质66Ibrutinib Impurity 66
Ibrutinib Impurity 66
CAS No.1839099-23-8
Chemical FormulaC26H28N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 67 structure
67
伊布替尼杂质67Ibrutinib Impurity 67
Ibrutinib Impurity 67
CAS No.1839099-44-3
Chemical FormulaC26H29N7O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 68 structure
68
伊布替尼杂质68Ibrutinib Impurity 68
Ibrutinib Impurity 68
CAS No.1906970-60-2
Chemical FormulaC26H29N7O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 69 structure
69
伊布替尼杂质69Ibrutinib Impurity 69
Ibrutinib Impurity 69
CAS No.2554619-82-6
Chemical FormulaC25H26N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 70 structure
70
伊布替尼杂质70Ibrutinib Impurity 70
Ibrutinib Impurity 70
CAS No.1288339-03-6
Chemical FormulaC25H26N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 71 structure
71
伊布替尼杂质71Ibrutinib Impurity 71
Ibrutinib Impurity 71
CAS No.1418272-84-0
Chemical FormulaC21H20N6O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 90 structure
90
伊布替尼杂质90Ibrutinib Impurity 90
Ibrutinib Impurity 90
CAS No.2052279-49-7
Chemical FormulaC25H24N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 91 structure
91
伊布替尼杂质91Ibrutinib Impurity 91
Ibrutinib Impurity 91
CAS No.3004963-21-4
Chemical FormulaC33H24N8O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 95 structure
95
伊布替尼杂质95Ibrutinib Impurity 95
Ibrutinib Impurity 95
CAS No.1839099-31-8
Chemical FormulaC23H24N6O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 97 structure
97
伊布替尼杂质97Ibrutinib Impurity 97
Ibrutinib Impurity 97
CAS No.1288339-18-3
Chemical FormulaC25H24N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 98 structure
98
伊布替尼杂质98Ibrutinib Impurity 98
Ibrutinib Impurity 98
CAS No.1839090-60-6
Chemical FormulaC25H24N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 115 structure
115
伊布替尼杂质115Ibrutinib Impurity 115
Ibrutinib Impurity 115
CAS No.5399-92-8
Chemical FormulaC5H3ClN4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 116 structure
116
伊布替尼杂质116Ibrutinib Impurity 116
Ibrutinib Impurity 116
CAS No.1260862-85-8
Chemical FormulaC5H4Cl2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 124 structure
124
伊布替尼杂质124Ibrutinib Impurity 124
Ibrutinib Impurity 124
CAS No.2031255-24-8
Chemical FormulaC25H23N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 127 structure
127
伊布替尼杂质127Ibrutinib Impurity 127
Ibrutinib Impurity 127
CAS No.1623-95-6
Chemical FormulaC13H9ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 128 structure
128
伊布替尼杂质128Ibrutinib Impurity 128
Ibrutinib Impurity 128
CAS No.1807619-68-6
Chemical FormulaC17H12ClN5O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 131 structure
131
伊布替尼杂质131Ibrutinib Impurity 131
Ibrutinib Impurity 131
CAS No.2437254-47-0
Chemical FormulaC25H24N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 140 structure
140
伊布替尼杂质140Ibrutinib Impurity 140
Ibrutinib Impurity 140
CAS No.2134109-10-5
Chemical FormulaC16H18N6O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 142 structure
142
伊布替尼杂质142Ibrutinib Impurity 142
Ibrutinib Impurity 142
CAS No.2803461-05-2
Chemical FormulaC20H19N5O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 143 structure
143
伊布替尼杂质143Ibrutinib Impurity 143
Ibrutinib Impurity 143
CAS No.448964-00-9
Chemical FormulaC11H19NO5
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 144 structure
144
伊布替尼杂质144Ibrutinib Impurity 144
Ibrutinib Impurity 144
CAS No.2540665-98-1
Chemical FormulaC50H48N12O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 145 structure
145
伊布替尼杂质145Ibrutinib Impurity 145
Ibrutinib Impurity 145
CAS No.1260664-81-0
Chemical FormulaC5H3ClN4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 149 structure
149
伊布替尼杂质149Ibrutinib Impurity 149
Ibrutinib Impurity 149
CAS No.1906970-58-8
Chemical FormulaC25H25ClN6O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 150 structure
150
伊布替尼杂质150Ibrutinib Impurity 150
Ibrutinib Impurity 150
CAS No.2380564-09-8
Chemical FormulaC10H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 151 structure
151
伊布替尼杂质151Ibrutinib Impurity 151
Ibrutinib Impurity 151
CAS No.1396709-98-0
Chemical FormulaC10H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 156 structure
156
伊布替尼杂质156Ibrutinib Impurity 156
Ibrutinib Impurity 156
CAS No.1516569-46-2
Chemical FormulaC17H14N4O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 157 structure
157
伊布替尼杂质157Ibrutinib Impurity 157
Ibrutinib Impurity 157
CAS No.21218-94-0
Chemical FormulaC14H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 158 structure
158
伊布替尼杂质158Ibrutinib Impurity 158
Ibrutinib Impurity 158
CAS No.143667-36-1
Chemical FormulaC13H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 160 structure
160
伊布替尼杂质160Ibrutinib Impurity 160
Ibrutinib Impurity 160
CAS No.1092788-11-8
Chemical FormulaC17H13N5O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 161 structure
161
伊布替尼杂质161Ibrutinib Impurity 161
Ibrutinib Impurity 161
CAS No.2230802-43-2
Chemical FormulaC17H13N5O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 163 structure
163
伊布替尼杂质163Ibrutinib Impurity 163
Ibrutinib Impurity 163
CAS No.2417548-83-3
Chemical FormulaC50H48N12O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 164 structure
164
伊布替尼杂质164Ibrutinib Impurity 164
Ibrutinib Impurity 164
CAS No.2417548-79-7
Chemical FormulaC50H48N12O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 166 structure
166
伊布替尼杂质166Ibrutinib Impurity 166
Ibrutinib Impurity 166
CAS No.2417548-81-1
Chemical FormulaC50H48N12O4
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 174 structure
174
伊布替尼杂质174Ibrutinib Impurity 174
Ibrutinib Impurity 174
CAS No.2417548-82-2
Chemical FormulaC47H46N12O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 176 structure
176
伊布替尼杂质176Ibrutinib Impurity 176
Ibrutinib Impurity 176
CAS No.1536245-34-7
Chemical FormulaC10H20N2O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 177 structure
177
伊布替尼杂质177Ibrutinib Impurity 177
Ibrutinib Impurity 177
CAS No.1689842-16-7
Chemical FormulaC8H14ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 179 structure
179
伊布替尼杂质179Ibrutinib Impurity 179
Ibrutinib Impurity 179
CAS No.2669746-30-7
Chemical FormulaC20H20N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 181 structure
181
伊布替尼杂质181Ibrutinib Impurity 181
Ibrutinib Impurity 181
CAS No.224818-64-8
Chemical FormulaC10H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 182 structure
182
伊布替尼杂质182Ibrutinib Impurity 182
Ibrutinib Impurity 182
CAS No.814916-95-5
Chemical FormulaC10H20N2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 183 structure
183
伊布替尼杂质183Ibrutinib Impurity 183
Ibrutinib Impurity 183
CAS No.99849-61-3
Chemical FormulaC10H20N2O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 188 structure
188
伊布替尼杂质188Ibrutinib Impurity 188
Ibrutinib Impurity 188
CAS No.2213398-76-4
Chemical FormulaC19H17N5O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 194 (N-Nitroso Ibrutinib Impurity 44) structure
194
伊布替尼杂质194 (N-亚硝基伊布替尼杂质44)Ibrutinib Impurity 194 (N-Nitroso Ibrutinib Impurity 44)
Ibrutinib Impurity 194 (N-Nitroso Ibrutinib Impurity 44)
CAS No.2256059-43-3
Chemical FormulaC22H21N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 197 structure
197
伊布替尼杂质197Ibrutinib Impurity 197
Ibrutinib Impurity 197
CAS No.127635-72-7
Chemical FormulaC17H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 198 structure
198
伊布替尼杂质198Ibrutinib Impurity 198
Ibrutinib Impurity 198
CAS No.2213398-77-5
Chemical FormulaC21H21N5O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 199 structure
199
伊布替尼杂质199Ibrutinib Impurity 199
Ibrutinib Impurity 199
CAS No.849928-30-9
Chemical FormulaC16H21NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 200 structure
200
伊布替尼杂质200Ibrutinib Impurity 200
Ibrutinib Impurity 200
CAS No.2243-42-7
Chemical FormulaC13H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 201 structure
201
伊布替尼杂质201Ibrutinib Impurity 201
Ibrutinib Impurity 201
CAS No.37951-15-8
Chemical FormulaC14H10O5
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 202 structure
202
伊布替尼杂质202Ibrutinib Impurity 202
Ibrutinib Impurity 202
CAS No.40586-47-8
Chemical FormulaC14H10O5
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 20-d9 structure
20-D9
伊布替尼杂质20-d9Ibrutinib Impurity 20-d9
Ibrutinib Impurity 20-d9
CAS No.2600364-57-4
Chemical FormulaC10H10D9NO3
Purity>95%询价On request
Ibrutinib Impurity 210 structure
210
伊布替尼杂质210Ibrutinib Impurity 210
Ibrutinib Impurity 210
CAS No.330785-90-5
Chemical FormulaC22H22N6O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 211 structure
211
伊布替尼杂质211Ibrutinib Impurity 211
Ibrutinib Impurity 211
CAS No.2417548-77-5
Chemical FormulaC28H26N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 214 structure
214
伊布替尼杂质214Ibrutinib Impurity 214
Ibrutinib Impurity 214
CAS No.3078124-63-4
Chemical FormulaC16H12N4O
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 219 structure
219
伊布替尼杂质219Ibrutinib Impurity 219
Ibrutinib Impurity 219
CAS No.21120-67-2
Chemical FormulaC13H9ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Ibrutinib Impurity 58-d8 structure
58-D8
伊布替尼杂质58-d8Ibrutinib Impurity 58-d8
Ibrutinib Impurity 58-d8
CAS No.1553977-73-3
Chemical FormulaC10H9D8NO3
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

伊布替尼 —— 研究文献与合成路线Ibrutinib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 伊布替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Ibrutinib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. A Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Ibrutinib Using QbD Approach by RP-HPLC, NMR Spectroscopy and ESI-MS
    Gopireddy RR, Maruthapillai A, Mahapatra S · Journal of chromatographic science · 2021 · 被引 3cited 3
  2. Development and validation of a stability-indicating ultra-high-performance liquid chromatography method for the estimation of ibrutinib and trace-level quantification of related substances using quality-by-design approach
    Prasad SK, Kalpana D · Biomedical chromatography : BMC · 2024 · 被引 2cited 2
  3. Structural Elucidation of Novel Degradation Impurities of Ibrutinib in Ibrutinib Tablets Using Preparative Chromatography, LCMS, HRMS and 2D NMR Techniques
    Yerla RR, Manubolusurya S, Meganathan S, et al. · Journal of chromatographic science · 2025
  4. Degradation of Bruton's tyrosine kinase mutants by PROTACs for potential treatment of ibrutinib-resistant non-Hodgkin lymphomas
    Sun Y, Ding N, Song Y, et al. · Leukemia · 2019 · 被引 116cited 116
  5. PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
    Sun Y, Zhao X, Ding N, et al. · Cell research · 2018 · 被引 240cited 240
  6. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway
    Mehta L, Naved T, Grover P, et al. · Journal of pharmaceutical and biomedical analysis · 2021 · 被引 19cited 19

合成路线文献Synthetic-route papers

  1. Integrative green synthesis and molecular simulation of ibrutinib cocrystals for enhanced biopharmaceutical performance and in vivo pharmacokinetics
    Kara DD, Bangera PD, Keerikkadu M, et al. · International journal of pharmaceutics: X · 2025
  2. Synthesis of One Carbon-14 Labelled [<sup>14</sup>C-pyrazolo]-Ibrutinib
    Su P, Dong B, Xu L, et al. · Journal of labelled compounds & radiopharmaceuticals · 2025
  3. Synthesis of 5-Amino-1<i>H</i>-pyrazole-4-carbonitriles from <i>N</i>-Tosylhydrazones and Its Application in the Preparation of Ibrutinib
    Zhang Q, Tang M · The Journal of organic chemistry · 2025

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

伊布替尼 杂质谱研究要点Ibrutinib — impurity profiling notes

下面这些是拿到 伊布替尼 的 96 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 96 impurity entries for Ibrutinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances